Skip to main content

Table 3 Distribution of the antimicrobial resistance profiles according to phylogroups

From: Molecular epidemiology of blaCTX-M gene-producing uropathogenic Escherichia coli among Iranian kidney transplant patients: clonal dissemination of CC131 and CC10

Antibiotics

B2

43

No. (%)

D

21

No. (%)

A

15

No. (%)

B1

10

No. (%)

C

6

No. (%)

E

5

No. (%)

F

4

No. (%)

Unknown

7

No. (%)

P value

Amoxicillin/clavulanic

14 (32.6)

10 (47.7)

5 (33.4)

4 (40)

0

0

1 (25)

2 (28.6)

> 0.05

Piperacillin–tazobactam

4 (9.3)

3 (14.3)

1 (6.7)

3 (30)

0

0

1 (25)

2 (28.6)

> 0.05

Cefoxitin

10 (23.3)

4 (19)

4 (26.7)

2 (20)

2 (33.3)

2 (40)

1 (25)

0

> 0.05

Ceftazidim

19 (44.2)

9 (42.9)

6(40)

5 (50)

2 (33.3)

1 (20)

2 (50)

1 (14.3)

> 0.05

Cefixim

20 (46.5)

13 (61.9)

5 (33.3)

5 (50)

2 (33.3)

0

1 (50)

3 (42.9)

> 0.05

Cefepime

12 (27.9)

3 (14.3)

4 (16.6)

2 (20)

5 (83.3)

0

2 (50)

1 (14.3)

> 0.05

Imipenem

0

0

0

0

0

0

0

0

> 0.05

Meropenem

0

0

0

0

0

0

0

0

> 0.05

Trimethoprim/sulfamethoxazole

24 (55.8)

13 (61.9)

9 (60)

8 (80)

4 (66.7)

4 (80)

3 (75)

5 (71.4)

> 0.05

Ciprofloxacin

22 (51.2)

8(38.1)

7 (46.7)

6 (60)

1 (16.7)

1 (20)

3 (75)

3 (42.9)

> 0.05

Ofloxacin

24 (55.8)

9 (42.9)

6 (40)

6 (60)

2 (33.3)

3 (60)

3 (75)

3 (42.9)

> 0.05

Nalidixic acid

32 (74.4)

15 (71.4)

10 (66.7)

8 (80)

3 (50)

3(60)

4 (100)

3 (42.9)

> 0.05

Norfloxacin

21 (48.8)

8 (38.1)

7 (46.7)

6 (60)

1 (16.7)

1 (20)

2 (50)

3 (42.9)

> 0.05

Nitrofurantoin

3 (7)

7 (33.3)

4 (26.7)

2 (20)

1 (16.7)

2 (40)

1 (25)

0

≤ 0.05

Gentamicin

12 (27.9)

(14.3) 3

4 (26.7)

3 (30)

1 (16.7)

3 (60)

0

0

> 0.05

Amikacin

0

0

0

1 (10)

0

0

0

1 (14.3)

> 0.05

Resistance score (mean, median, range)

4.88, 5, (0–11)

4.9±, 5, (0–11)

4.33, 3, (0–11)

5.5, 6, (0–11)

2.83, 2, (0–8)

4, 4, (0–8)

5.5, 5, (0–10)

3.7, 3, (0–9)

> 0.05

ESBL

17(39.5)

7 (33.3)

4 (26.6)

2 (20)

2 (33.3)

1 (20)

2 (50)

–

> 0.05

CTX-M

25 (58.1)

11 (52.4)

8 (53.3)

3 (30)

3 (50)

2 (40)

1 (25)

6 (85.7)

> 0.05

TEM

20 (46.5)

12 (57.1)

7 (46.7)

2 (20)

2 (33.3)

2 (40)

2 (50)

3 (42.9)

> 0.05

SHV

1 (2.3)

2 (9.5)

1 (6.7)

1 (10)

–

–

–

1 (14.3)

> 0.05